These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34923287)

  • 1. Molecular simulations reveal the impact of RAMP1 on ligand binding and dynamics of calcitonin gene-related peptide receptor (CGRPR) heterodimer.
    Aksoydan B; Durdagi S
    Comput Biol Med; 2022 Feb; 141():105130. PubMed ID: 34923287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual drug repurposing study for the CGRPR identifies pentagastrin and leuprorelin as putative candidates.
    Aksoydan B; Durdagi S
    J Mol Graph Model; 2022 Nov; 116():108254. PubMed ID: 35803082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism.
    ter Haar E; Koth CM; Abdul-Manan N; Swenson L; Coll JT; Lippke JA; Lepre CA; Garcia-Guzman M; Moore JM
    Structure; 2010 Sep; 18(9):1083-93. PubMed ID: 20826335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
    Moore EL; Gingell JJ; Kane SA; Hay DL; Salvatore CA
    Biochem Biophys Res Commun; 2010 Mar; 394(1):141-5. PubMed ID: 20188075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
    Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
    Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To Probe the Binding Interactions between Two FDA Approved Migraine Drugs (Ubrogepant and Rimegepant) and Calcitonin-Gene Related Peptide Receptor (CGRPR) Using Molecular Dynamics Simulations.
    Leung L; Liao S; Wu C
    ACS Chem Neurosci; 2021 Jul; 12(14):2629-2642. PubMed ID: 34184869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.
    Sheykhzade M; Amandi N; Pla MV; Abdolalizadeh B; Sams A; Warfvinge K; Edvinsson L; Pickering DS
    Vascul Pharmacol; 2017 Mar; 90():36-43. PubMed ID: 28192258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refolding and characterization of a soluble ectodomain complex of the calcitonin gene-related peptide receptor.
    Koth CM; Abdul-Manan N; Lepre CA; Connolly PJ; Yoo S; Mohanty AK; Lippke JA; Zwahlen J; Coll JT; Doran JD; Garcia-Guzman M; Moore JM
    Biochemistry; 2010 Mar; 49(9):1862-72. PubMed ID: 20099900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM structure of the active, G
    Liang YL; Khoshouei M; Deganutti G; Glukhova A; Koole C; Peat TS; Radjainia M; Plitzko JM; Baumeister W; Miller LJ; Hay DL; Christopoulos A; Reynolds CA; Wootten D; Sexton PM
    Nature; 2018 Sep; 561(7724):492-497. PubMed ID: 30209400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.
    Edvinsson L; Eftekhari S; Salvatore CA; Warfvinge K
    Mol Cell Neurosci; 2011 Jan; 46(1):333-9. PubMed ID: 21040789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
    Woolley MJ; Reynolds CA; Simms J; Walker CS; Mobarec JC; Garelja ML; Conner AC; Poyner DR; Hay DL
    Biochem Pharmacol; 2017 Oct; 142():96-110. PubMed ID: 28705698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein-Ligand Complexes.
    Cansfield AD; Ator MA; Banerjee J; Bestwick M; Bortolato A; Brown GA; Brown J; Butkovic K; Cansfield JE; Christopher JA; Congreve M; Cseke G; Deflorian F; Dugan B; Hunjadi MP; Hutinec A; Inturi TK; Landek G; Mason J; O'Brien A; Ott GR; Rupcic R; Saxty G; Southall SM; Zadravec R; Watson SP
    ACS Chem Neurosci; 2022 Mar; 13(6):751-765. PubMed ID: 35245037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ECL2 in CGRP receptor activation: a combined modelling and experimental approach.
    Woolley MJ; Watkins HA; Taddese B; Karakullukcu ZG; Barwell J; Smith KJ; Hay DL; Poyner DR; Reynolds CA; Conner AC
    J R Soc Interface; 2013 Nov; 10(88):20130589. PubMed ID: 24047872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP and Gs Protein.
    Cao J; Belousoff MJ; Danev R; Christopoulos A; Wootten D; Sexton PM
    Biochemistry; 2024 May; 63(9):1089-1096. PubMed ID: 38603770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaffinity Cross-Linking and Unnatural Amino Acid Mutagenesis Reveal Insights into Calcitonin Gene-Related Peptide Binding to the Calcitonin Receptor-like Receptor/Receptor Activity-Modifying Protein 1 (CLR/RAMP1) Complex.
    Simms J; Uddin R; Sakmar TP; Gingell JJ; Garelja ML; Hay DL; Brimble MA; Harris PW; Reynolds CA; Poyner DR
    Biochemistry; 2018 Aug; 57(32):4915-4922. PubMed ID: 30004692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
    Salvatore CA; Mallee JJ; Bell IM; Zartman CB; Williams TM; Koblan KS; Kane SA
    Biochemistry; 2006 Feb; 45(6):1881-7. PubMed ID: 16460034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptor.
    Barwell J; Miller PS; Donnelly D; Poyner DR
    Peptides; 2010 Jan; 31(1):170-6. PubMed ID: 19913063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Ligand Binding to Calcitonin Gene-Related Peptide Receptors.
    Deganutti G; Atanasio S; Rujan RM; Sexton PM; Wootten D; Reynolds CA
    Front Mol Biosci; 2021; 8():720561. PubMed ID: 34513925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine.
    Moore EL; Salvatore CA
    Br J Pharmacol; 2012 May; 166(1):66-78. PubMed ID: 21871019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function analysis of RAMP1 by alanine mutagenesis.
    Simms J; Hay DL; Bailey RJ; Konycheva G; Bailey G; Wheatley M; Poyner DR
    Biochemistry; 2009 Jan; 48(1):198-205. PubMed ID: 19072332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.